OOncovision — No stage disclosed · €1.14M
The molecular-imaging (PET) maker raised a €1.139M follow-on from CDTI Innvierte (€539k), Bullnet Capital II and CRB Bio II. The money funds clinical trials of its CareMiBrain brain PET and a new Sentinella version.
Lead not disclosed
RoundNo stage disclosed
Announced11 Dec 2020 · as Oncovision (General Equipment for Medical Imaging)
CityValencia
SectorHealthtech & Bio · Medtech
Source
C
C
